Evolution of the Mesenteric Mass in Small Intestinal Neuroendocrine Tumours

SIMPLE SUMMARY: Around two-thirds of patients with small intestinal neuroendocrine tumours are present with a metastatic mesenteric mass. This mass is known to cause intestinal complications, however, little is known on its development over time in the era of targeted therapy. Therefore, we conducte...

Descripción completa

Detalles Bibliográficos
Autores principales: Blažević, Anela, Brabander, Tessa, Zandee, Wouter T., Hofland, Johannes, Franssen, Gaston J. H., van Velthuysen, Marie-Louise F., Feelders, Richard A., De Herder, Wouter W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865677/
https://www.ncbi.nlm.nih.gov/pubmed/33503893
http://dx.doi.org/10.3390/cancers13030443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865677/
https://www.ncbi.nlm.nih.gov/pubmed/33503893
http://dx.doi.org/10.3390/cancers13030443

Ejemplares similares